CartiHeal Announces Pivotal Study Results Demonstrate Agili-C(TM) Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects

According to a Two-Year Randomized and Controlled Multinational IDE Study KFAR SABA, Israel, Aug. 3, 2021 -- (Healthcare Sales & Marketing Network) -- CartiHeal Ltd, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in... Devices, Orthopaedic CartiHeal, Agili-C, osteoarthritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news